Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.
Discover the results of two recent clinical studies of IVIg treatments for CIDP.
Hear why SCIg may be a better option for long-term treatment of patients on Immunoglobulin therapy with difficult venous access.
Discover the results of two recent clinical studies of IVIg treatments for CIDP.